- •The rapid test for antibodies to SARS-COV-2 was 90.1% sensitive and 100% specific.
- •This is comparable to reference antibody tests for prior infection with COVID-19.
- •It could support clinical decision-making for patients with >10 days of symptoms.
- •It would be useful in settings where vaccination is not widespread.
- •And where PCR tests are not widely available.
- Use of lateral flow devices allows rapid triage of patients with SARS-CoV-2 on admission to hospital.J Infect. 2021; 82: 276-316
- Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis.BMJ. 2020; 370: m2516
- Development and Clinical Application of A rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.J Med Virol. 2020; 92: 1518-1524
Bell J.Trouble in Testing Land. https://www.research.ox.ac.uk/Article/2020-04-05-trouble-in-testing-land (accessed 22/04/ 2020).
Vancheeswaran R., Willcox M.L., Stuart B., et al. Accuracy of rapid point-of-care antibody test in patients with suspected or confirmed COVID-19. medRxiv 2020:2020.11.17.20233296.
Reuters. Denmark to send back inaccurate antibody tests from China's Livzon. https://www.reuters.com/article/us-health-coronavirus-denmark-kits-idUSKBN22W2TC (accessed 12 Oct 2020).
- Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test.J Med Virol. 2020; 92: 2004-2010